滲透性糖蛋白(Pgp)重組蛋白
Recombinant Permeability Glycoprotein (Pgp)
CD243; ABCB1; ABC20; CLCS; GP170; MDR1; PGY1; P-Glycoprotein; Multidrug resistance protein 1; ATP-Binding Cassette,Sub-Family B(MDR/TAP),Member 1; Colchicin Sensitivity
- 編號RPB690Ra01
- 物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜, 分泌
- 預測分子量33.8kDa
- 實際分子量34kDa(差異分析請參閱說明書)
- 片段與標簽Ala999~Ser1277 with N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 90%
- 等電點9.1
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 816 ¥ 2040 ¥ 4080 ¥ 12240 ¥ 30600
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
序列
![](http://static.cloud-clone.cn/product/pictures/RPB690Ra01-202201191631473055.jpg)
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB690Ra01 | 滲透性糖蛋白(Pgp)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB690Ra01 | 滲透性糖蛋白(Pgp)多克隆抗體 | WB; IHC; ICC; IP. |
SEB690Ra | 滲透性糖蛋白(Pgp)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB690Ra | 滲透性糖蛋白(Pgp)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
International Forum of Allergy & Rhinology | P-glycoprotein promotes epithelial T helper 2–associated cytokine secretion in chronic sinusitis with nasal polyps [Onlinelibrary: alr.21316] |
International Forum of Allergy & Rhinology | P‐glycoprotein regulates Staphylococcus aureus enterotoxin B–stimulated interleukin‐5 and thymic stromal lymphopoietin secretion in organotypic mucosal explants [PubMed: 26625351] |
American Journal of Rhinology & Allergy | Intact?soluble?P-glycoprotein?is?secreted?by?sinonasal?epithelial?cells. [pubmed:27456593] |
The Laryngoscope | Secreted P-glycoprotein is a noninvasive biomarker of chronic rhinosinusitis [pubmed:27577924] |
Materials Science and Engineering: C | Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia [] |
Molecular Cancer | Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance [Pubmed: 31830995] |
留言咨詢